Immunovant (IMVT) Shares Outstanding (Entity) (2018 - 2026)
Immunovant (IMVT) posted Shares Outstanding (Entity) of 206.26 million for fiscal Q1 2027 (quarter ended Jun 30, 2026), up 20.6% from 171.07 million a year earlier and up 1.1% from the prior quarter.
Powered by 
Analysis
Immunovant (IMVT) Shares Outstanding (Entity) (2018 - 2026) Analysis & Trends
For FY2026 (ended Mar 31, 2026), Immunovant's Shares Outstanding (Entity) came in at 203.94 million, up 19.9% from FY2025.
- Annual Shares Outstanding (Entity) has increased for seven consecutive fiscal years, with a five-year compound annual growth rate of 15.8% (FY2021 to FY2026).
- In prior fiscal years, Immunovant's Shares Outstanding (Entity) was 170.11 million in FY2025 (+16.8%), 145.58 million in FY2024 (+11.7%), 130.33 million in FY2023 (+11.9%) and 116.48 million in FY2022 (+18.9%).
- The fiscal Q1 2027 figure stands as the highest quarterly Shares Outstanding (Entity) in data going back to fiscal Q3 2019.
- On a year-over-year basis, Shares Outstanding (Entity) has increased in each of the last 27 quarters, with growth averaging 18.1% over the last eight quarters.
- Across the past five years, year-over-year growth in Shares Outstanding (Entity) ran from 1.4% in fiscal Q2 2023 to 38.1% in fiscal Q3 2026.
- According to Business Quant data, Shares Outstanding (Entity) for the three prior fiscal quarters was 203.94 million (Q4 2026), 203.32 million (Q3 2026) and 174.53 million (Q2 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Entity.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 2.41 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 1.77 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 2.47 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 540.60 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 1.24 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 5.70 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 253.35 Mn |
| 10 | Immunovant | 6.97 Bn | 6.97 Bn | - | 206.26 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 206.26 Mn |
| Mar 31, 2026 | 203.94 Mn |
| Dec 31, 2025 | 203.32 Mn |
| Sep 30, 2025 | 174.53 Mn |
| Jun 30, 2025 | 171.07 Mn |
| Mar 31, 2025 | 170.11 Mn |
| Dec 31, 2024 | 147.20 Mn |
| Sep 30, 2024 | 146.57 Mn |
| Jun 30, 2024 | 146.20 Mn |
| Mar 31, 2024 | 145.58 Mn |
| Dec 31, 2023 | 145.09 Mn |
| Sep 30, 2023 | 131.44 Mn |
| Jun 30, 2023 | 130.57 Mn |
| Mar 31, 2023 | 130.33 Mn |
| Dec 31, 2022 | 129.26 Mn |
| Sep 30, 2022 | 116.61 Mn |
| Jun 30, 2022 | 116.52 Mn |
| Mar 31, 2022 | 116.48 Mn |
| Dec 31, 2021 | 115.11 Mn |
| Sep 30, 2021 | 115.00 Mn |
API Access
Immunovant Shares Outstanding (Entity) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding-entity&ticker=IMVT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding-entity", "ticker": "IMVT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding-entity&ticker=IMVT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();